⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Byondis nomme Christoph Korpus, au poste de directeur général
businesswire.com
MRK
Byondis ernennt Christoph Korpus, PhD, MBA, zum Chief Executive Officer
businesswire.com
MRK
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)
globenewswire.com
TERN
WSR
RLYB
DAWN
MRK
ARES
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
globenewswire.com
MRK
Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts for 33.21% Share, with Asia-Pacific as the Fastest-Growing Region, Says Mordor Intelligence
prnewswire.com
TMO
MRK
Global Keloid Treatment Market Outlook | North America, Asia Pacific, Europe Lead | Bausch Health, Sciton, Galderma Drive Multi-Modal Dermatology Innovation
accessnewswire.com
BHC
MRK
Primrose Bio Function Generator™ Combinatorial Genetic Technology Case Study Published in PNAS
prnewswire.com
JAZZ
MRK
$30.16+ BN Functional Service Providers Market Forecasts to 2034: Rising Trial Complexity, Cost Pressures, Demand for Flexible & Scalable Outsourcing Models
globenewswire.com
PFE
MRK
JNJ
Jeito Capital Hits Record $1.2 Billion (€1 Billion) 1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients
businesswire.com
MRK
BIIB
Phanes Therapeutics announces dose expansion in clinical study of spevatamig in combination with chemotherapy for treatment of biliary tract cancer
prnewswire.com
MRK